Short answer
CVS Health (CVS) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). CVS Health reported results for the three months ended September 30, 2026.
CVS Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- CVS Health reported results for the three months ended September 30, 2026
- Press release issued November 4, 2026, with financial details in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $108.4B, up 5.4% YoY, with adjusted operating income rising 21.2% to $4.2B
- Adjusted EPS $2.09, up from $1.60, driven primarily by Health Care Benefits margin recovery
- Health Care Benefits MBR improved to 91.3% from 92.8%, while adjusted operating income rose to $912M
- Full-year guidance raised: adjusted EPS at least $8.20, GAAP EPS at least $6.98, operating cash flow at least $15.5B
- Key risk remains elevated medical cost trends, despite 26.1M medical members and favorable prior-year cost development of $1.3B
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CVS Health 8-K filings
Get the next CVS 8-K as it lands
Follow CVS for push alerts, or ask the research agent what this filing means.